Recombinant Human TNK Tissue-type Plasminogen Activator for Injection (CSPC Recomgen Pharmaceutical (Guangzhou) Co Ltd)

注射用重组人TNK组织型纤溶酶原激活剂（石药集团明复乐药业）

Report date: 2025/07/07 17:59:33

Base Information

Drug NameRecombinant Human TNK Tissue-type Plasminogen Activator for Injection (CSPC Recomgen Pharmaceutical (Guangzhou) Co Ltd)
Drug Alias Name注射用重组人TNK组织型纤溶酶原激活剂（广州铭康生物）Recombinant Human TNK Tissue-type Plasminogen Activator for InjectionTenecteplase (CSPC Recomgen Pharmaceutical (Guangzhou) Co Ltd)替奈普酶 (石药集团明复乐药业（广州）有限公司)Tenecteplase (CSPC Recomgen Pharma) +[11] 
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionPlasminogen stimulants
TargetsPlasminogen
Therapy Area/IndicationsIschemic StrokeMyocardial InfarctionStroke
Global Approved IndicationsMyocardial Infarction
Approved Indications in ChinaMyocardial Infarction
Original Approved Country/TerritoryMainland China
Original Approved Date2015/01/14
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesCSPC Recomgen Pharmaceutical (Guangzhou) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCSPC Mingfule Pharmaceutical (Guangzhou) Co LtdCSPC Recomgen Pharmaceutical (Guangzhou) Co Ltd
Inactive CompaniesN/A
Active IndicationsIschemic StrokeMyocardial InfarctionStroke
Inactive IndicationsN/A

Other Information

ATC CodeB01A
Related LinksN/A